Study type

Study type

Non-interventional study

Scope of the study

Drug utilisation
Non-interventional study

Non-interventional study design

Cohort
Cross-sectional
Study drug and medical condition

Name of medicine, other

Spiolto Respimat

Anatomical Therapeutic Chemical (ATC) code

(R01AD) Corticosteroids
Corticosteroids

Medical condition to be studied

Chronic obstructive pulmonary disease
Population studied

Age groups

Adults (18 to < 46 years)
Adults (46 to < 65 years)
Adults (65 to < 75 years)
Adults (75 to < 85 years)
Adults (85 years and over)

Estimated number of subjects

300
Study design details

Main study objective

To describe and compare the sociodemographic, anthropometric and clinical characteristics of COPD patients at the time of prescription of a new maintenance regimen with TIO/OLO or an ICS-containing regimen (free or fixed dose triple combination ICS/LABA/LAMA, LABA+ICS, LAMA+ICS, ICS monotherapy or other) in the Portuguese primary care setting.

Outcomes

Demographic, anthropometric and clinical characteristics in the two study cohorts. Includes the number of patients for whom the new COPD treatment is in accordance with the GOLD 2019 Guideline recommendations, Patient symptomatology according to mMRC questionnaire and QoL according to EQ-5D-5L in the two study cohorts, Overall patient satisfaction with inhaler device according to a 5-point Likert scale and treatment satisfaction according to TSQM in the two study cohorts,

Data analysis plan

All quantitative variables will be summarized using descriptive statistics. All qualitative variables will be summarized by absolute (n) and relative (%) frequencies. The statistical analysis will be performed through frequency tables for qualitative variables and tables with descriptive statistics for quantitative variables. A logistic regression will be used to explore the association between the dependent variable and independent variables of interest.